EOM Pharmaceutical Holdings Inc. (IMUC)

[SC777]

$IMUC summary:

IMUC:

-Zero debt.
-Former NYSE biotech.
-41 million OS.
-$3.5 million in cash on balance sheet.
-Trading at a market cap of $800,000.
-Company being shopped by management for a merger/buyout (confirmed by IR as of 12/14/18)- with NO debt, all proceeds go to shareholders :)
-Valuable cancer IP and a CLEAN shell for merger.
-October 15, 2018 PR: "ImmunoCellular may continue efforts to pursue opportunities for partnerships, licensing or sale of its anticancer assets and research programs, and monetization of the its dendritic cell-based and Stem-to-T-cell intellectual property . . . . . . ."